Joerg Faber

4.1k citations
42 papers · 2.9k indexed · 2 hit papers · h-index 16

Joerg Faber

37 papers receiving 2.8k citations

Hit Papers

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Me...64220062026201220192505007501000

Peers

Joerg Faber
Comparison fields: 5 of 99
  • Hematology 1.2k
  • Molecular Biology 1.9k
  • Cancer Research 294
  • Genetics 197
  • Immunology 359
Replace Scott Cooper with:
Scott Cooper United States
Andrew Dunbar United States
Melvin Churchill United States
Sarah K. Meadows United States
Robert S. Welner United States
Roland Fenk Germany
Stephen M. Denning United States
Fabio Morandi Italy
W A Galloway United Kingdom
Takashi Taga Japan
Joerg Faber relative to Scott Cooper United States Scott Cooper's profile →
Citations per field
00.5×2.6×
Scott Cooper · 1×
Citations per year

Countries citing papers authored by Joerg Faber

Since Specialization
Citations

This map shows the geographic impact of Joerg Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Faber more than expected).

Fields of papers citing papers by Joerg Faber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Faber. The network helps show where Joerg Faber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joerg Faber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joerg Faber Line = papers co-authored together Joerg Faber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20251
5 20242
6 20234
7 20231
8 20205
9 20176
10 201731
11 201618
12
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1Lbreakdown →
2011642
13 201028
14 2008396
15 200811
16 200736
17 20071
18 200265
19 199930
20 19965

About Joerg Faber

Joerg Faber is a scholar working on Hematology, Microbiology and Speech and Hearing, having authored 42 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Neuroblastoma Research and Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Adolescent and Pediatric Healthcare (3 papers), Bacterial Infections and Vaccines (3 papers), CAR-T cell therapy research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (1.2k citations), Molecular Biology (1.9k citations) and Cancer Research (294 citations). Joerg Faber has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Scott A. Armstrong, Andrei V. Krivtsov, Zhaohui Feng, Matthew C. Stubbs, Andrew L. Kung, D. Gary Gilliland, David Twomey, Jason Levine, Jing Wang and William C. Hahn. Their work appears in journals such as Nature, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026